Navigate this market better. Subscribe for FREE stock alerts and information.

Monday, January 28, 2013

Nordion explores strategic alternatives, (NYSE: NDZ)

Medical isotopes provider Nordion Inc said it has initiated a review of its strategic alternatives, almost four months after it suspended its dividend as an arbitration panel rejected its claim for damages from its main supplier. No decision has been made to enter into any specific deal, and the Canadian company said it intends to continue with planned business activities throughout the review process. [ID: nBw285375a]

Nordion Inc. (Nordion), formerly MDS Inc. is a global life sciences company that provides products and services for the prevention, diagnosis and treatment of disease. Shares of NDZ remained unchanged at $6.39. In the past year, the shares have traded as low as $5.51 and as high as $10.96. On average, 139495 shares of NDZ exchange hands on a given day and today's volume is recorded at 0.